Rapid product developments by manufacturers and their increasing number of approvals by the U.S. FDA are the factors augmenting the growth of the Asian breast implants market.
Breast implants are artificial surgery prosthesis made of either silicone gel, silica or saline solutions, which involves reconstruction of breasts to improve the effects of mastectomy or other damages to breasts. This breast implantation procedure is also called as breast augmentation. Breast implant and its reconstruction requires tissue expanders that helps in the expansion of breast muscles and skin. A permanent breast implant is inserted post removal of the tissue expander. Breast implant procedure is performed mostly in an outpatient basis, which takes only an hour or two to finish the implantation process. However, the surgery time can be extended depending on the patient’s condition of breasts, the type of implant to be used, and other factors.
Click To Continue Reading on Asian Breast Implants Market
The Asian Breast Implants market size is estimated to be valued at US$ 140.93 Mn in 2017 and is expected to witness a robust CAGR of 7.0% during the forecast period (2018 - 2026).
There are few complications and adverse outcomes of breast implants, which could hamper growth of breast implants market. This includes additional surgeries with or without removal of the device, capsular contracture, occurrence of scar tissue around the implant and squeezes the implant, breast pain, changes in nipple and breast sensation, rupture with deflation of saline-filled implants, rupture with or without symptoms (silent rupture) of silicone gel-filled implants.
Key Vendors:
Allergen, Inc., Mentor Worldwide LLC, GC Aesthetics Plc, Johnson & Johnson, POLYTECH Health and Aesthetics GmBH, Groupe Sebbin SAS, Arion Laboratories, HansBiomed Co.Ltd. and GG Biotechnology Ltd.
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1806
Contact Us:
Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Tel: +1-206-701-6702Email: sales@coherentmarketinsights.com
Visit our news Website: https://www.coherenttimes.org/
Aspergillosis Treatment Market Opportunity Analysis, 2018-2026
Patent expiration of branded products and drug resistance to antifungal medications are the factors restraining growth of the market.
Measles Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2018 – 2026
Vaccine manufacturers are focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines.
PoC Platform & Technology Market to Surpass US$ 45.4 Billion by 2025
The global POC platform & technology market was valued at US$ 21,370.3 Million in 2016 and is expected to exhibit a robust CAGR of 8.9% over the forecast period (2017 – 2025).
